Role of SH Levels and Markers of Immune Response in the Stroke

Table 2

Clinical and laboratory parameters of 50 patients with brain stroke divided in function of NIHSS score ≤30 and >30.

	Age (yrs)	VCAM	BDNF	ICAM	MMP2–9
(A) NIHSS ≤ 30; 𝑛. 30; (M. 20, F. 10)	67.3±13.0	519±205	43.23 (13.94–337.4)	248.6±86.6	124.2±64.1
(B) NIHSS > 30; 𝑛. 20; (M. 11, F. 9)	70.3±7.98	683.2±404.0	121.8 (20–1303.9)	360.35±179.71	239.6±152.5
A versus B	𝑃=0.36	𝑃=0.064	𝑃=0.0001	𝑃=0.005	𝑃=0.0006
Control groups	55 (35–70)	15.96±4.024	14.24±6.88	201.2±55.0	—

VCAM: Cytokine-induced cell adhesion molecule (ng/mL); BDNF: Brain-derived neurotrophic factor (pg/mL); ICAM: intercellular adhesion molecules (pg/mL); MMP2–9: matrix metalloprotease 2–9 (units/ug protein).